30 September 2003
Genentech’s CEO on Big Pharma’s Issues
Genentech’s CEO on Big Pharma’s Issues
Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research
Biotech Blog
Genentech’s CEO on Big Pharma’s Issues
Arthur Levinson tackles drug pricing, patent disputes, consumer marketing, and stem-cell research
Yali Friedman lives in Washington, DC and is author of Building Biotechnology. He is also founder of DrugPatentWatch.com, and has a long history in biotechnology media. read more…
